| Literature DB >> 24893004 |
Noriaki Yokogawa1, Hideki Murakami1, Satoru Demura1, Satoshi Kato1, Katsuhito Yoshioka1, Hiroyuki Hayashi1, Takayoshi Ishii1, Takashi Igarashi1, Xiang Fang1, Hiroyuki Tsuchiya1.
Abstract
BACKGROUND: Total en bloc spondylectomy (TES) is associated with a high complication rate because it is technically demanding and involves patients compromised by cancer. Specifically, perioperative complications are more likely to occur in patients receiving preoperative irradiation. We examined the perioperative complications associated with TES in patients receiving preoperative irradiation.Entities:
Mesh:
Year: 2014 PMID: 24893004 PMCID: PMC4043789 DOI: 10.1371/journal.pone.0098797
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Operative schema for total en bloc spondylectomy.
(A) Pediculotomy using a T-saw and en bloc resection of the posterior element; (B) Anterior column osteotomy and removal of the tumor-affected vertebral body.
Demographic and surgical characteristics of patients.
| RT-TES | TES |
| |
|
| 59.7±12.1 | 56.7±12.7 | 0.418 |
|
| 11∶7 | 16∶16 | 0.454 |
|
| 23.9±2.8 | 22.8±3.2 | 0.120 |
|
| 6 (33.3) | 11 (34.4) | 0.941 |
|
| 4 (22.2) | 2 (6.3) | 0.099 |
|
| 2.3±0.5 | 2.1±0.3 | 0.092 |
|
| 7 (38.9) | 5 (15.6) | 0.067 |
|
| 3 (16.7) | 4 (12.5) | 0.687 |
|
| 8 (44.4) | 8 (25.0) | 0.161 |
|
| 2 (11.1) | 2 (6.3) | 0.547 |
|
| 3.8±0.4 | 4±0.4 | 0.205 |
|
| 3.7±2.1 | 4.8±1.2 | 0.081 |
|
| 467.7±99.8 | 420.4±84.6 | 0.102 |
|
| 683.1±695.7 | 702.5±1046.3 | 0.656 |
|
| 2.1±0.9 | 1.6±0.8 | 0.061 |
|
| 3.7±1.9 | 3.2±1.5 | 0.359 |
RT-TES, patients undergoing total en bloc spondylectomy with preoperative irradiation;
TES, patients undergoing total en bloc spondylectomy, only;
ASA, American Society of Anesthesiologists; Numbers in parentheses denotes the percentage.
Perioperative complications.
| RT-TES | TES |
| |
|
| 7 (38.9) | 1 (3.1) | <0.001 |
|
| 0 (0) | 0 (0) | ― |
|
| 0 (0) | 0 (0) | ― |
|
| 11 (64.7) | 3 (9.4) | <0.001 |
|
| 4 (22.2) | 0 (0) | 0.006 |
|
| 7 (38.9) | 2 (6.2) | 0.005 |
|
| 1 (5.6) | 1 (3.1) | 0.677 |
|
| 14 (77.8) | 6 (18.8) | <0.001 |
RT-TES, patients undergoing total en bloc spondylectomy with preoperative irradiation;
TES, patients undergoing total en bloc spondylectomy, only;
SSI, surgical site infection;
CSF, cerebrospinal fluid.
*Statistical significance.
Influence of total dose and time interval between the end of irradiation and surgery for perioperative complications in patients undergoing total en bloc spondylectomy with preoperative irradiation (RT-TES).
| No. | Age | Sex | Total dose (Gy) | Time interval between irradiation and surgery (months) | Intraoperative dural injury | Postoperative CSF | Wound dehiscence | Pleural effusion | Neurological deficit |
|
| 67 | M | 41.5 | 9 | - | + | - | - | - |
|
| 73 | M | 55 | 22 | - | - | + | + | - |
|
| 68 | F | 56 | 39 | + | + | - | + | - |
|
| 54 | F | 64 | 23 | + | + | - | + | - |
|
| 67 | F | 30 | 4 | - | + | - | - | - |
|
| 42 | M | 40 | 36 | - | - | - | - | - |
|
| 53 | F | 60 | 12 | - | - | - | - | - |
|
| 62 | F | 50 | 161 | + | + | + | - | - |
|
| 49 | M | 30 | 25 | - | - | - | + | - |
|
| 62 | M | 30 | 1 | - | + | - | - | - |
|
| 75 | F | 36 | 2 | - | - | - | - | - |
|
| 65 | M | 30 | 8 | - | + | - | - | - |
|
| 59 | F | 30 | 57 | + | - | - | - | - |
|
| 56 | M | 40 | 21 | + | + | - | - | - |
|
| 26 | M | 39 | 2 | - | - | - | - | - |
|
| 59 | M | 40 | 3 | - | + | + | + | + |
|
| 65 | M | 82.5 | 16 | + | + | + | + | - |
|
| 73 | M | 50 | 2 | + | + | - | + | - |
CSF, cerebrospinal fluid.
Complication rates associated with total irradiation dose.
| Total dose | <40 Gy (n = 7) n (%) | ≥40 Gy (n = 11) n (%) |
|
|
| 1 (14.3) | 6 (54.5) | 0.097 |
|
| 3 (42.9) | 8 (72.7) | 0.218 |
|
| 0 (0) | 4 (36.4) | 0.079 |
|
| 1 (14.3) | 6 (54.5) | 0.097 |
|
| 5 (71.4) | 9 (81.8) | 0.691 |
CSF, cerebrospinal fluid.
Complication rates associated with the time interval between the end of irradiation and surgery.
| Time interval between irradiation and surgery | <12 months (n = 8) n (%) | ≥12 months (n = 10) n (%) |
|
|
| 1 (12.5) | 6 (60.0) | 0.046 |
|
| 6 (75.0) | 5 (50.0) | 0.293 |
|
| 1 (12.5) | 3 (30.0) | 0.388 |
|
| 2 (25.0) | 5 (50.0) | 0.293 |
|
| 6 (75.0) | 8 (80.0) | 0.805 |
CSF, cerebrospinal fluid.
*Statistical significance.